Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Receivables (2019 - 2026)

Immatics (IMTX) posted Receivables of $7.1 million for Q4 2025, up 89.84% sequentially from $3.7 million in Q3 2025, and up 13.43% YoY from $6.3 million in Q4 2024.

Analysis

Immatics (IMTX) Receivables (2019 - 2026) Analysis & Trends

Immatics has reported Receivables for 7 years, with the latest figure at $7.1 million in Q4 2025.

  • Quarterly Receivables rose 13.43% year-over-year to $7.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.1 million (up 13.43% YoY) and the FY2025 annual result came in at $6.9 million, up 8.7% from the prior year.
  • Receivables climbed to $7.1 million in Q4 2025 per IMTX's latest filing, from $3.7 million in the prior quarter.
  • Over five years, Receivables peaked at $7.1 million in Q4 2025 and troughed at $247942.0 in Q1 2023.
  • A 5-year average of $2.3 million and a median of $1.1 million in 2022 frame the typical range for Receivables.
  • The sharpest annual moves came in 2023 and 2024: Receivables tumbled 70.23% in 2023, then surged 742.4% in 2024.
  • Over 5 years, Receivables stood at $780188.2 in 2021, then jumped by 45.28% to $1.1 million in 2022, then jumped by 288.52% to $4.4 million in 2023, then surged by 42.12% to $6.3 million in 2024, then climbed by 13.43% to $7.1 million in 2025.
  • According to Business Quant data, Receivables over the past three periods registered $7.1 million, $3.7 million, and $2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 2.13 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 6.57 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.93 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 160.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.06 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 912.74 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 215.33 Mn
10 Immatics 1.17 Bn 711.21 Mn - 6.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.54 Mn
Mar 31, 2026 4.86 Mn
Dec 31, 2025 7.10 Mn
Sep 30, 2025 3.74 Mn
Jun 30, 2025 2.22 Mn
Mar 31, 2025 5.89 Mn
Dec 31, 2024 6.30 Mn
Sep 30, 2024 3.24 Mn
Jun 30, 2024 3.03 Mn
Mar 31, 2024 1.93 Mn
Dec 31, 2023 4.41 Mn
Sep 30, 2023 559,535.51
Jun 30, 2023 359,345.05
Mar 31, 2023 247,941.96
Dec 31, 2022 1.13 Mn
Sep 30, 2022 1.15 Mn
Jun 30, 2022 1.03 Mn
Mar 31, 2022 832,774.59
Dec 31, 2021 800,779.67
Sep 30, 2021 854,983.31